研究简报

1-羟基异喹啉及羟基Fasudil 的合成

  • 陈美珠 ,
  • 刘帅 ,
  • 王欣然 ,
  • 罗浩 ,
  • 陈立功 ,
  • 王东华
展开
  • a 天津大学化工学院精细化工系 天津 300072;
    b 天津大学药物科学与技术学院 天津 300072

收稿日期: 2011-05-25

  修回日期: 2011-08-29

  网络出版日期: 2012-03-09

Synthesis of 1-Isoquinolinol and Hydroxyfasudil

  • CHEN Mei-Zhu ,
  • LIU Shuai ,
  • WANG Xin-Ran ,
  • LUO Hao ,
  • CHEN Li-Gong ,
  • WANG Dong-Hua
Expand
  • a Institute of Chemical Engineering and Technology, Tianjin University, Tianjin 300072;
    b School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072

Received date: 2011-05-25

  Revised date: 2011-08-29

  Online published: 2012-03-09

摘要

首先以异喹啉为原料, 经氧化生成氮氧化物后与苯甲酰氯和水作用, 得到1-羟基异喹啉, 收率为73.3%. 以Fasudil 为原料, 经氨基保护、氧化, 在相转移催化剂的存在下, 于二氯甲烷和水的两相体系中与苯甲酰氯和水作用, 合成羟基Fasudil, HPLC 纯度大于99%, 总收率为46.8%, 从而建立了一条条件温和、操作简便的羟基Fasudil 的合成工艺路线.

本文引用格式

陈美珠 , 刘帅 , 王欣然 , 罗浩 , 陈立功 , 王东华 . 1-羟基异喹啉及羟基Fasudil 的合成[J]. 有机化学, 2012 , 32(02) : 404 -408 . DOI: 10.6023/cjoc1105252

Abstract

1-Isoquinolinol was synthesized from isoquinoline via oxidation, reaction with benzoyl chloride and water in yield of 73.3%. According to this process, a method for the synthesis of hydroxyfasudil [1-(1-hydroxy-5-isoquinolinesulfonyl)- homopiperazine] from fasudil [hexahydro-1-(5-isoquinoline-sulfonyl)-1H-1,4-diazepine] was estabilshed in this paper. The process undergoes effectively through protection for amino, oxidation, reaction with water in a water/dichloromethane biphase system in the presence of phase transfer catalyst and benzoyl chloride and then deprotection. The objective product was finally obtained in yield of 46.8% with a purity more than 99% (HPLC). It is virtually a practical process with mild reaction conditions and simple operation.

参考文献

[1] Satoh, S.; Suzuki, Y.; Harada, T.; Ikegaki, I.; Asano, T.; Shibuya, M.; Sugita, K.; Hidaka, H. Eur. J. Pharmacol. 1992, 220, 243.

[2] Masayuki, I.; Atusuya, T.; Yuji, O.; Takehisa, K.; Yoshimichi, T.; Hiroshi, O.; Motoko, S.; Terumi, S.; Kayoko, F.; Hiroshi, I. Bioorg. Med. Chem. 2007, 15, 350.

[3] Dedmer, S.; Reinoud, G.; Johan, Z.; Andrew, J. H.; Herman, M. Eur. J. Pharmacol. 2008, 585, 398.

[4] Duan, W.-G.; Yuan, S.-T.; Liao, H.; Yan, M.; Zhang, L.-Y. Acta Pharmacol. Sin. 2007, 42, 1013 (in Chinese). (段为钢, 袁胜涛, 廖红, 严明, 张陆勇, 药学学报, 2007, 42, 1013.)

[5] Chen, G.-Y.; Lu, S.-M.; Zhou, Y.-G. Chin. J. Org. Chem. 2006, 26, 1548 (in Chinese). (陈英国, 卢胜梅, 周永贵, 有机化学, 2006, 26, 1548.)

[6] Frisch, K.; Landa, A.; Saaby, S.; Jфrgensen, K. A. Angew. Chem., Int. Ed. 2005, 44, 6058.

[7] Harjit, S.; Sunil, K. A.; Nageshwar, M. Synth. Commun. 1983, 791.

[8] Alan, R. K.; Andrzej, R. L. Energy Fuels 1992, 6, 439.

[9] Hayashida, M.; Honda, H.; Hamana, M. Heterocycles 1990, 31, 1325.

[10] Daniel, B.; Richard, J. D.; Jeremy, D.; Frances, C. A. G.; Steve, L.; Stephen, R. M.; Ray, O.; Verity, S.; Joanne, W. Bioorg. Med. Chem. Lett. 2007, 17, 562.

[11] Zhou, L.-S.; Feng, Y.-Q.; Zhang, W.; Qu, H.-M. Chem. Propellants Polym. Mater. 1999, 28 (in Chinese). (周立山, 冯亚青, 张伟, 曲红梅, 化学推进剂与高分子材料, 1999, 28.)

[12] Hiromu, K.; Masaru, O. WO 9702260, 1997 [Chem. Abstr. 1997, 126, 157526].

[13] Huang, Z.-H. CN 101092413, 2007 [Chem. Abstr. 2008, 148, 151915].

[14] Han, M.-L. M.S. Thesis, Tianjian University, Tianjin, 2009 (in Chinese). (韩美玲, 硕士论文, 天津大学, 天津, 2009.)
文章导航

/